Total planned funding: $371,803,321
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $371,803,321 |
Organizational Types
NGO | $96,370,760 |
Private Contractor | $66,089,014 |
Own Agency | $57,357,795 |
Host Country Government Agency | $50,585,711 |
University | $39,706,070 |
Unknown | $39,192,243 |
Parastatal | $7,008,403 |
Implementing Agency | $5,093,893 |
Other USG Agency | $4,132,709 |
Multi-lateral Agency | $3,190,000 |
FBO | $3,076,723 |
Program Areas
Treatment | $110,801,637 |
Prevention | $75,947,901 |
Care | $73,955,291 |
Governance and Systems | $48,596,953 |
Management and Operations | $36,764,765 |
Testing | $25,736,774 |
Budget Codes
HTXS: Treatment: Adult Treatment | $92,266,486 |
HVMS: Management and Operations | $36,764,765 |
HKID: Care: Orphans and Vulnerable Children | $28,936,976 |
HVCT: Testing: HIV Testing and Counseling | $25,736,774 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,320,790 |
OHSS: Health Systems Strengthening | $22,716,932 |
HBHC: Care: Adult Care and Support | $21,495,404 |
HVSI: Strategic Information | $20,040,481 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $18,741,270 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,551,442 |
HVTB: Care: TB/HIV | $15,133,066 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,953,516 |
PDTX: Treatment: Pediatric Treatment | $10,136,658 |
HTXD: Treatment: ARV Drugs | $8,398,493 |
PDCS: Care: Pediatric Care and Support | $8,389,845 |
HLAB: Laboratory Infrastructure | $5,839,540 |
HMBL: Biomedical Prevention: Blood Safety | $2,752,458 |
HMIN: Biomedical Prevention: Injection Safety | $628,425 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
USG Aggregated Agencies:
$48,031,661
Countries/Regions
Potentia Namibia:
$42,460,238
Countries/Regions
Not Available:
$38,520,603
Countries/Regions